Pharmaceutical Market Europe • March 2025 • 20
THOUGHT LEADER
By Caroline Phillips
Medical affairs teams are at the forefront of shaping the healthcare landscape by driving evidence-based decision-making, enhancing scientific engagement and ensuring the appropriate use of therapies.
As pharmaceutical companies invest billions in these initiatives, the demand for accountability and demonstrable impact has never been higher. However, the eternal challenge remains: how do we ensure that our efforts lead to meaningful outcomes? Innovation in outcomes measurement is transforming this landscape, moving beyond traditional metrics and offering measurable results that redefine success.
In the realm of medical education and engagement, measuring metrics such as reach and participation has been standard practice. While valuable, this approach stops short of demonstrating real-world change. The true test of medical affairs activities lies in outcomes: observable shifts in healthcare professional (HCP) behaviour, ultimately leading to improved patient care. Advanced outcomes-driven approaches bridge this gap by providing a clear picture of how interventions influence clinical decisions and ultimately, improve patient outcomes.
Outcomes measurement is not just about accountability; it’s about creating a culture of continuous improvement. By understanding what works and what doesn’t, medical affairs teams can refine their strategies, optimise resource allocation and ensure that their activities truly support better healthcare delivery.
Key aspects of outcomes measurement include:
Effective outcomes measurement is grounded in a robust, data-driven framework. This begins with defining key outcomes in advance, ensuring that every programme is designed to achieve measurable goals. The framework includes:
Outcomes-driven solutions are already demonstrating their value across various settings. These approaches track the impact of medical education activities and, in the US, can go as far as analysing hard outcomes such as prescribing behaviours, coding practices and patient health metrics. Outside the US, measurement of key performance indicators (KPIs) like knowledge and confidence changes, and intention to change clinical practice provides an acceptable surrogate for hard outcomes.
One standout feature of these methodologies is their ability to assess both knowledge and behavioural outcomes. Importantly, this data-driven approach also allows pharma stakeholders to get a measure of return on their investments in outcomes measurement and the programme as a whole.
Despite the clear benefits, measuring outcomes in medical affairs activities has historically faced significant challenges. Many initiatives lack the necessary permissions and capabilities to collect and analyse data at this level. Collaborative platforms and data-sharing frameworks enable the tracking of engagement and outcomes while respecting privacy and compliance standards.
Partnership-based approaches allow organisations to leverage expertise and infrastructure for outcomes measurement. By working with platform partners such as Medscape, companies gain access to:
The ability to reliably measure outcomes has the potential to transform medical affairs, shifting it from a supportive function to a strategic driver of healthcare innovation. By focusing on outcomes, organisations can:
Medscape’s unique approach to outcomes in medical affairs exemplifies these principles in action. By leveraging our extensive data ecosystem and advanced analytics, Medscape offers a seamless integration of education, engagement and measurable outcomes. Through personalised engagement strategies, precision tracking of real-world behaviours and guaranteed results, Medscape sets a new standard for accountability and impact in medical affairs initiatives.
Leadership in outcomes-driven education and engagement is setting a new standard for medical affairs. The message is clear: in an era where accountability and results matter more than ever, embracing outcomes measurement provides the tools to lead the way.
Caroline Phillips is Vice President of Medscape Global Medical Affairs